Atrial fibrillation in the Indigenous populations of Australia, Canada, New Zealand, and the United States: A systematic scoping review

BMC Cardiovascular Disorders

Volumn 15, Issue 1, 2015, Pages

  Katzenellenbogen, Judith M ^a   Woods, John A ^a   Teng, Tiew Hwa Katherine ^a   Thompson, Sandra C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

AGE DISTRIBUTION; ARTICLE; ATRIAL FIBRILLATION; AUSTRALIA; CANADA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONSULTATION; DISEASE SURVEILLANCE; HEALTH CARE DISPARITY; HEALTH CARE SYSTEM; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HOSPITALIZATION; HUMAN; INCIDENCE; INDIGENOUS PEOPLE; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; NEW ZEALAND; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLICATION; RHEUMATIC HEART DISEASE; SEX DIFFERENCE; SYSTEMATIC REVIEW; UNITED STATES; VENTRICULAR MASS INDEX; VETERAN; AMERICAN INDIAN; EPIDEMIOLOGY; ETHNOLOGY; HEALTH DISPARITY; OCEANIC ANCESTRY GROUP; STATISTICS AND NUMERICAL DATA;

ATRIAL FIBRILLATION; AUSTRALIA; CANADA; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PREVALENCE; UNITED STATES;

EID: 84938854307     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-015-0081-6     Document Type: Article

References (83)

1. Donato R, Segal L. Does Australia have the appropriate health reform agenda to close the gap in Indigenous health? Aust Health Rev. 2013;37(2):232-8.
2. Statistics New Zealand. New Zealand Period Life Tables: 2010-12. Wellington: Statistics New Zealand; 2013.
3. Life expectancy: Gap in life expectancy projected to decrease between Aboriginal people and the total Canadian population. Accessed 6 Aug, 2015 [ http://www.statcan.gc.ca/pub/89-645-x/2010001/c-g/c-g013-eng.htm ]
4. Daniel M, Lekkas P, Cargo M. Environments and cardiometabolic diseases in aboriginal populations. Heart Lung Circ. 2010;19(5-6):306-15.
5. Vasilevska M, Ross SA, Gesink D, Fisman DN. Relative risk of cervical cancer in indigenous women in Australia, Canada, New Zealand, and the United States: a systematic review and meta-analysis. J Public Health Policy. 2012;33(2):148-64.
6. Cooke M, Mitrou F, Lawrence D, Guimond E, Beavon D. Indigenous well-being in four countries: an application of the UNDP'S human development index to indigenous peoples in Australia, Canada, New Zealand, and the United States. BMC Int Health Hum Rights. 2007;7:9.
7. Carson KV, Brinn MP, Labiszewski NA, Peters M, Chang AB, Veale A, et al. Interventions for tobacco use prevention in Indigenous youth. Cochrane Database Syst Rev. 2012;8:Cd009325.
8. Clifford AC, Doran CM, Tsey K. A systematic review of suicide prevention interventions targeting indigenous peoples in Australia, United States, Canada and New Zealand. BMC Public Health. 2013;13:463.
9. Chamberlain C, Yore D, Li H, Williams E, Oldenburg B, Oats J, et al. Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand, and the United States: a method for systematic review of studies with different designs. BMC Pregnancy Childbirth. 2011;11:104.
10. United Nations Department of Economic and Social Affairs. The State of the World's Indigenous Peoples (STA/ESA/328 Sales No. E.09.VI.13). New York: United Nations Publications; 2009.
11. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation. 1999;99(18):2389-95.
12. Vos T, Barker B, Begg S, Stanley L, Lopez AD. Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol. 2009;38(2):470-7.
13. Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167(5):1807-24.
14. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-47.
15. Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012;142(6):1489-98.
16. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15(4):486-93.
17. Wasilewska M, Gosk-Bierska I. Thromboembolism associated with atrial fibrillation as a cause of limb and organ ischemia. Adv Clin Exp Med. 2013;22(6):865-73.
18. Ahmad Y, Lip GY, Lane DA. Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke. Can J Cardiol. 2013;29(7 Suppl):S4-13.
19. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology. 2007;69(6):546-54.
20. Task Force for the Management of Atrial Fibrillation (European Society of Cardiology). Guidelines for the management of atrial fibrillation. Eur Heart J. 2010;31(19):2369-429.
21. Andersson T, Magnuson A, Bryngelsson IL, Frobert O, Henriksson KM, Edvardsson N, et al. All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013;34(14):1061-7.
22. Leong DP, Eikelboom JW, Healey JS, Connolly SJ. Atrial fibrillation is associated with increased mortality: causation or association? Eur Heart J. 2013;34(14):1027-30.
23. Brown A, Walsh W, Lea T, Tonkin A. What becomes of the broken hearted? Coronary heart disease as a paradigm of cardiovascular disease and poor health among Indigenous australians. Heart Lung Circ. 2005;14(3):158-62.
24. Dang D, Patel R, Haywood LJ. Atrial fibrillation in a multiethnic inpatient population of a large public hospital. J Natl Med Assoc. 2004;96(11):1438-44.
25. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed 6 Aug, 2015 [ http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm ]
26. Wong C, Cheng Y, Lau D, Leong D, Brooks A, Shipp N, et al. Atrial Fibrillation in Indigenous Aboriginal Australians. Heart Lung Circ. 2010;19:S255.
27. Katzenellenbogen JM, Teng TH, Lopez D, Sanfilippo F, Knuiman M, Hobbs M, et al. Abstract PM265: The epidemiological profile of first-ever hospitalisations for atrial fibrillation in Aboriginal and non-Aboriginal Western Australians, 2000-2009. Global Heart. 2014; 6(1S):e115.
28. Atzema CL, Kapral M, Klein-Geltink J, Asllani E. Cardiovascular Disease in the Métis Nation of Ontario: Technical Report. Toronto: Métis Nation of Ontario/Institute for Clinical Evaluative Sciences; 2012.
29. Wong CX, Brooks AG, Cheng YH, Lau DH, Rangnekar G, Roberts-Thomson KC, et al. Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study. BMJ Open. 2014;4(10), e006242.
30. Katzenellenbogen JM, Teng TH, Lopez D, Hung J, Knuiman MW, Sanfilippo FM, et al. Initial hospitalisation for atrial fibrillation in Aboriginal and non-Aboriginal populations in Western Australia. Heart. 2015;101(9):712-9.
31. Atzema CL, Khan S, Lu H, Allard YE, Russell SJ, Gravelle MR, et al. Cardiovascular Disease Rates, Outcomes, and Quality of Care in Ontario Métis: A Population-Based Cohort Study. PLoS ONE. 2015;10(3), e0121779.
32. Zacks ES, Okin PM, Min J, Roman MJ, Lee ET, Howard BV, et al. Abstract 3203: Association of Markers of Inflammation with New-Onset Atrial Fibrillation in a Population-Based Sample: The Strong Heart Study. Circulation. 2006;114(II):678.
33. Zacks ES, Okin PM, Min J, Roman MJ, Lee ET, Howard BV, et al. Abstract 2591: Association of Left Ventricular Mass and Ejection Fraction with New-Onset Atrial Fibrillation in a Population-Based Sample: The Strong Heart Study. Circulation. 2006;114(II):536.
34. Borzecki AM, Bridgers DK, Liebschutz JM, Kader B, Kazis LE, Berlowitz DR. Racial differences in the prevalence of atrial fibrillation among males. J Natl Med Assoc. 2008;100(2):237-45.
35. Brown A, Carrington MJ, McGrady M, Lee G, Zeitz C, Krum H, et al. Cardiometabolic risk and disease in Indigenous Australians: the Heart of the Heart Study. Int J Cardiol. 2014;171(3):377-83.
36. McGrady M, Krum H, Carrington MJ, Stewart S, Zeitz C, Lee GA, et al. Heart failure, ventricular dysfunction and risk factor prevalence in Australian Aboriginal peoples: the Heart of the Heart Study. Heart. 2012;98(21):1562-7.
37. Martin A, Doughty RN, Chieng N, Faatoese A, Gamble GD, Poppe K, et al. Twelve Lead Electrocardiographic Findings Among Maori and non-Maori at Risk of Cardiovascular Disease in NZ. Heart Lung Circ. 2013;22:569.
38. Teh RO, Martin A, Kerse N, Dyall L, Doughty RN. The Burden of Atrial Fibrillation in Octogenarians. Heart Lung Circ. 2013;22:580.
39. New Zealand Guidelines Group. The Management of People with Atrial Fibrillation and Flutter: Evidence-based Best Practice Guideline. Wellington: NZGG; 2005.
40. Australian Institute of Health and Welfare. Aboriginal and Torres Strait Islander Health Performance Framework 2012: detailed analyses. Cat. no. IHW 94. Canberra: AIHW; 2013.
41. Turagam MK, Velagapudi P, Visotcky A, Szabo A, Kocheril AG. African Americans have the highest risk of in-hospital mortality with atrial fibrillation related hospitalizations among all racial/ethnic groups: A nationwide analysis. Int J Cardiol. 2012;158(1):165-6.
42. Nazeri A, Razavi M, Elayda MA, Lee VV, Massumi A, Wilson JM. Race/ethnicity and the incidence of new-onset atrial fibrillation after isolated coronary artery bypass surgery. Heart Rhythm. 2010;7(10):1458-63.
43. Lyons KJ, Ezekowitz JA, Liu W, McAlister FA, Kaul P. Mortality outcomes among status Aboriginals and Whites with Heart Failure. Can J Cardiol. 2014;30(6):619-26.
44. Teng TH, Katzenellenbogen JM, Thompson SC, Sanfilippo FM, Knuiman M, Geelhoed E, et al. Incidence of first heart failure hospitalisation and mortality in Aboriginal and non-Aboriginal patients in Western Australia, 2000-2009. Int J Cardiol. 2014;173(1):110-7.
45. Dancaster CP, Tait RC. Ischaemic heart disease in New Zealand Maori and non-Maori: an age adjusted incidence in hospitalised patients over 10 years with emphasis on clinical features in the Maori. Aust N Z J Med. 1982;12(4):267-70.
46. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011;22(2):349-57.
47. Goldstein BA, Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012;126(19):2293-301.
48. To AC, Yehia M, Collins JF. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply? Nephrology (Carlton). 2007;12(5):441-7.
49. Katzenellenbogen JM, Knuiman MW, Sanfilippo FM, Hobbs MS, Thompson SC. Prevalence of stroke and coexistent conditions: disparities between indigenous and nonindigenous Western Australians. Int J Stroke. 2014;9 Suppl A100:61-8.
50. Nakagawa K, Koenig MA, Seto TB, Asai SM, Chang CW. Racial disparities among Native Hawaiians and Pacific Islanders with intracerebral hemorrhage. Neurology. 2012;79(7):675-80.
51. Nakagawa K, Koenig MA, Asai SM, Chang CW, Seto TB. Disparities among Asians and native Hawaiians and Pacific islanders with ischemic stroke. Neurology. 2013;80(9):839-43.
52. McCann AB, Walters DL, Aroney CN. Percutaneous balloon mitral commissurotomy in Indigenous versus non-Indigenous Australians. Heart Lung Circ. 2008;17(3):200-5.
53. Russell EA, Tran L, Baker RA, Bennetts JS, Brown A, Reid CM, et al. A review of valve surgery for rheumatic heart disease in Australia. BMC Cardiovasc Disord. 2014;14:134.
54. Sood MM, Tangri N, Komenda P, Rigatto C, Khojah S, Hiebert B, et al. Incidence, secular trends, and outcomes of cardiac surgery in Aboriginal peoples. Can J Cardiol. 2013;29(12):1629-36.
55. Rohde SL, Matebele M, Pohlner P, Radford D, Wall D, Fraser JF. Excellent cardiac surgical outcomes in paediatric indigenous patients, but follow-up difficulties. Heart Lung Circ. 2010;19(9):517-22.
56. Remenyi B, Webb R, Finucane K, Sidhu K, Gentles T, Wilson N. Preoperative risk factors for long-term survival following cardiac surgery for rheumatic heart disease in the young. Circulation. 2012;125(19), e723.
57. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104(22):2746-53.
58. Anand SS, Yusuf S, Jacobs R, Davis AD, Yi Q, Gerstein H, et al. Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). Lancet. 2001;358(9288):1147-53.
59. Brown A, Brieger D, Tonkin A, White H, Walsh W, Riddell T, et al. Coronary disease in indigenous populations: summary from the CSANZ indigenous Cardiovascular Health Conference. Heart Lung Circ. 2010;19(5-6):299-305.
60. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-292.
61. Steer AC, Carapetis JR. Acute rheumatic fever and rheumatic heart disease in indigenous populations. Pediatr Clin North Am. 2009;56(6):1401-19.
62. Tobias M, Yeh LC, Wright C, Riddell T, Chan WC, Jackson R, et al. The burden of coronary heart disease in Maori: population-based estimates for 2000-02. Aust N Z J Public Health. 2009;33(4):384-7.
63. Amponsah MK, Benjamin EJ, Magnani JW: Atrial Fibrillation and Race - A Contemporary Review. Curr Cardiovasc Risk Rep. 2013;7(5):336-345.
64. Gbadebo TD, Okafor H, Darbar D. Differential impact of race and risk factors on incidence of atrial fibrillation. Am Heart J. 2011;162(1):31-7.
65. The Strong Heart Study. Accessed 6 Aug, 2015 [ http://strongheart.ouhsc.edu/ ]
66. Marcus GM, Alonso A, Peralta CA, Lettre G, Vittinghoff E, Lubitz SA, et al. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation. 2010;122(20):2009-15.
67. Graham GN, Guendelman M, Leong BS, Hogan S, Dennison A. Impact of heart disease and quality of care on minority populations in the United States. J Natl Med Assoc. 2006;98(10):1579-86.
68. Hayman N. Strategies to improve indigenous access for urban and regional populations to health services. Heart Lung Circ. 2010;19(5-6):367-71.
69. Lopez D, Katzenellenbogen JM, Sanfilippo FM, Woods JA, Hobbs MS, Knuiman MW, et al. Disparities experienced by Aboriginal compared to non-Aboriginal metropolitan Western Australians in receiving coronary angiography following acute ischaemic heart disease: the impact of age and comorbidities. Int J Equity Health. 2014;13(1):93.
70. Prystowsky EN, Camm J, Lip GY, Allessie M, Bergmann JF, Breithardt G, et al. The impact of new and emerging clinical data on treatment strategies for atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(8):946-58.
71. Brown A. Acute Coronary Syndromes in Indigenous Australians: Opportunities for Improving Outcomes Across the Continuum of Care. Heart Lung Circ. 2010;19(5-6):325-36.
72. Lowres N, Neubeck L, Redfern J, Freedman SB. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost. 2013;110(2):213-22.
73. Wong CX, Lee SW, Gan SW, Mahajan R, Rangnekar G, Pathak RK, et al. Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians. Int J Cardiol. 2015;191:20-4.
74. Brown AD, Morrissey MJ, Sherwood JM. Uncovering the determinants of cardiovascular disease among Indigenous people. Ethn Health. 2006;11(2):191-210.
75. Parker EJ, Jamieson LM, Broughton J, Albino J, Lawrence HP, Roberts-Thomson K. The oral health of Indigenous children: a review of four nations. J Paediatr Child Health. 2010;46(9):483-6.
76. Glover M, Kira A, Johnston V, Walker N, Thomas D, Chang AB, et al. A systematic review of barriers and facilitators to participation in randomized controlled trials by Indigenous people from New Zealand, Australia, Canada and the United States. Glob Health Promot. 2015;22(1):21-31.
77. DiGiacomo M, Davidson PM, Abbott PA, Davison J, Moore L, Thompson SC. Smoking cessation in indigenous populations of Australia, New Zealand, Canada, and the United States: elements of effective interventions. Int J Environ Res Public Health. 2011;8(2):388-410.
78. Bowen A, Duncan V, Peacock S, Bowen R, Schwartz L, Campbell D, et al. Mood and anxiety problems in perinatal Indigenous women in Australia, New Zealand, Canada, and the United States: a critical review of the literature. Transcult Psychiatry. 2014;51(1):93-111.
79. Boeker M, Vach W, Motschall E. Google Scholar as replacement for systematic literature searches: good relative recall and precision are not enough. BMC Med Res Methodol. 2013;13:131.
80. Turner AM, Liddy ED, Bradley J, Wheatley JA. Modeling public health interventions for improved access to the gray literature. J Med Libr Assoc. 2005;93(4):487-94.
81. Hartling L, Milne A, Hamm MP, Vandermeer B, Ansari M, Tsertsvadze A, et al. Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers. J Clin Epidemiol. 2013;66(9):982-93.
82. Randall DA, Lujic S, Leyland AH, Jorm LR. Statistical methods to enhance reporting of Aboriginal Australians in routine hospital records using data linkage affect estimates of health disparities. Aust N Z J Public Health. 2013;37(5):442-9.
83. Thompson SC, Woods JA, Katzenellenbogen JM. The quality of indigenous identification in administrative health data in Australia: insights from studies using data linkage. BMC Med Inform Decis Mak. 2012;12:133.